Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.15 billion. The enterprise value is $883.06 million.
Important Dates
The last earnings date was Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 159.30 million shares outstanding. The number of shares has increased by 79.29% in one year.
| Current Share Class | 159.30M |
| Shares Outstanding | 159.30M |
| Shares Change (YoY) | +79.29% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 64.53% |
| Float | 122.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.51 |
| Forward PS | 17.30 |
| PB Ratio | 4.37 |
| P/TBV Ratio | 4.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.29.
| Current Ratio | 10.22 |
| Quick Ratio | 9.89 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.44 |
Financial Efficiency
Return on equity (ROE) is -57.19% and return on invested capital (ROIC) is -31.18%.
| Return on Equity (ROE) | -57.19% |
| Return on Assets (ROA) | -27.21% |
| Return on Invested Capital (ROIC) | -31.18% |
| Return on Capital Employed (ROCE) | -55.89% |
| Revenue Per Employee | $217,690 |
| Profits Per Employee | -$703,325 |
| Employee Count | 274 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 53.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.94% in the last 52 weeks. The beta is 1.50, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +24.94% |
| 50-Day Moving Average | 7.41 |
| 200-Day Moving Average | 8.46 |
| Relative Strength Index (RSI) | 47.39 |
| Average Volume (20 Days) | 1,532,602 |
Short Selling Information
The latest short interest is 12.98 million, so 8.15% of the outstanding shares have been sold short.
| Short Interest | 12.98M |
| Short Previous Month | 14.10M |
| Short % of Shares Out | 8.15% |
| Short % of Float | 10.57% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
In the last 12 months, OCUL had revenue of $59.65 million and -$192.71 million in losses. Loss per share was -$1.15.
| Revenue | 59.65M |
| Gross Profit | -95.67M |
| Operating Income | -205.68M |
| Pretax Income | -138.36M |
| Net Income | -192.71M |
| EBITDA | -201.83M |
| EBIT | -205.68M |
| Loss Per Share | -$1.15 |
Full Income StatementBalance Sheet
The company has $349.68 million in cash and $76.22 million in debt, giving a net cash position of $273.46 million or $1.72 per share.
| Cash & Cash Equivalents | 349.68M |
| Total Debt | 76.22M |
| Net Cash | 273.46M |
| Net Cash Per Share | $1.72 |
| Equity (Book Value) | 265.93M |
| Book Value Per Share | 1.67 |
| Working Capital | 349.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$145.46 million and capital expenditures -$2.97 million, giving a free cash flow of -$148.43 million.
| Operating Cash Flow | -145.46M |
| Capital Expenditures | -2.97M |
| Free Cash Flow | -148.43M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
| Gross Margin | -160.40% |
| Operating Margin | -344.83% |
| Pretax Margin | -323.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -79.29% |
| Shareholder Yield | -79.29% |
| Earnings Yield | -16.66% |
| FCF Yield | -12.83% |
Analyst Forecast
The average price target for OCUL is $16.11, which is 123.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.11 |
| Price Target Difference | 123.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 61.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 1 |